NASDAQ:MOTS - Motus GI Stock Price, Forecast & News

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

Motus GI Holdings Inc (NASDAQ:MOTS) announced its quarterly earnings results on Thursday, November, 14th. The company reported ($0.18) earnings per share for the quarter, beating analysts' consensus estimates of ($0.25) by $0.07. View Motus GI's Earnings History.

Motus GI is scheduled to release their next quarterly earnings announcement on Wednesday, March 25th 2020. View Earnings Estimates for Motus GI.

2 analysts have issued 1 year price objectives for Motus GI's shares. Their forecasts range from $6.00 to $10.00. On average, they anticipate Motus GI's stock price to reach $7.67 in the next twelve months. This suggests a possible upside of 295.2% from the stock's current price. View Analyst Price Targets for Motus GI.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Motus GI.

Media stories about MOTS stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Motus GI earned a news impact score of -1.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Motus GI.

Some companies that are related to Motus GI include Vapotherm (VAPO), Soliton (SOLY), TELA Bio (TELA), RenovaCare (RCAR), Cytosorbents (CTSO), Pulse Biosciences (PLSE), Liquidia Technologies (LQDA), BRAINSWAY LTD/S (BWAY), Spectral Medical (EDTXF), PAVmed (PAVM), SANUWAVE Health (SNWV), BeyondAirInc . (XAIR), Sensus Healthcare (SRTS), Pro-Dex (PDEX) and Nephros (NEPH).

Based on aggregate information from My MarketBeat watchlists, some companies that other Motus GI investors own include Canopy Growth (CGC), Advanced Micro Devices (AMD), NVIDIA (NVDA), Alibaba Group (BABA), Sorrento Therapeutics (SRNE), Zynerba Pharmaceuticals (ZYNE), Verizon Communications (VZ), Corbus Pharmaceuticals (CRBP), Heron Therapeutics (HRTX) and Netflix (NFLX).

(MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Motus GI's stock is owned by many different of retail and institutional investors. Top institutional investors include Trellus Management Company LLC (0.78%), Magnetar Financial LLC (0.72%) and Eaton Vance Management (0.10%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Larry N Feinberg, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Institutional Ownership Trends for Motus GI.

MOTS stock was sold by a variety of institutional investors in the last quarter, including Magnetar Financial LLC and Eaton Vance Management. View Insider Buying and Selling for Motus GI.

MOTS stock was bought by a variety of institutional investors in the last quarter, including Trellus Management Company LLC. Company insiders that have bought Motus GI stock in the last two years include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Larry N Feinberg, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View Insider Buying and Selling for Motus GI.

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MOTS stock can currently be purchased for approximately $1.94.

Motus GI has a market capitalization of $55.86 million and generates $40,000.00 in revenue each year. The company earns $-22,260,000.00 in net income (profit) each year or ($1.23) on an earnings per share basis. Motus GI employs 44 workers across the globe.View Additional Information About Motus GI.

The official website for Motus GI is http://www.motusgi.com/.

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 954-541-8000 or via email at [email protected]